Literature DB >> 9185521

In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma.

K E Foreman1, P E Bacon, E D Hsi, B J Nickoloff.   

Abstract

Several lines of investigation point to a new herpesvirus, human herpesvirus-8 (HHV-8), as the cause of two different neoplasms seen in AIDS patients-Kaposi's sarcoma (KS) and body cavity B cell lymphoma. If this virus is the etiological agent, rather than another opportunistic infectious agent, it should be present in the earliest detectable clinical lesions on a temporal basis, and localize to specific target cells in a spatial pattern consistent with tumorigenic pathways. In this study, we take advantage of the clinical accessibility to biopsy early (patch stage) skin lesions of KS to address the temporal issue, combined with in situ PCR and dual immunostaining using a marker identifying malignant cells, to address the spatial localization issue. 21 different tissue samples were subjected to PCR analysis and in situ PCR with and without simultaneous immunostaining. In normal skin from healthy individuals, no HHV-8 DNA was detected by PCR or in situ PCR. However, in all PCR-positive tissues, distinct and specific in situ PCR staining was observed. In four different patch stage KS lesions, in situ PCR staining localized to nuclei of endothelial cells and perivascular spindle-shaped tumor cells. Later stage KS lesions (plaques and nodules) revealed additional positive cells, including epidermal keratinocytes (four of five), and eccrine epithelia (two of four). These patterns were nonrestricted to skin, as pulmonary KS also revealed HHV-8-specific infection of endothelial cells and KS tumor cells, as well as epithelioid pneumocytes (two of two). In body cavity B cell lymphoma by dual staining, HHV-8 was present in malignant tumor cells (EMA immunostained positive) and not in reactive lymphocytes. These results reveal an early temporal onset and nonrandom tissue and cellular distribution pattern for HHV-8 infection that is consistent with a causal link between this DNA virus and two AIDS-related neoplasms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185521      PMCID: PMC508149          DOI: 10.1172/JCI119492

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  Three new human herpesviruses (HHV6, 7, and 8).

Authors:  J A Levy
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

Review 2.  In-situ polymerase chain reaction. An overview of methods, applications and limitations of a new molecular technique.

Authors:  P Komminoth; A A Long
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

3.  Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections. Detection of viral DNA, gene rearrangements and chromosomal translocations.

Authors:  A A Long; P Komminoth; E Lee; H J Wolfe
Journal:  Histochemistry       Date:  1993-02

4.  Pitfalls of in situ polymerase chain reaction (PCR) using direct incorporation of labelled nucleotides.

Authors:  J F Sällström; I Zehbe; M Alemi; E Wilander
Journal:  Anticancer Res       Date:  1993 Jul-Aug       Impact factor: 2.480

5.  In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations.

Authors:  L M Weiss; L A Movahed
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

6.  The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin (alpha M beta 2, Mac-1) and promotes leukocyte adhesion.

Authors:  D C Altieri; J Plescia; E F Plow
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

7.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.

Authors:  N Dupin; M Grandadam; V Calvez; I Gorin; J T Aubin; S Havard; F Lamy; M Leibowitch; J M Huraux; J P Escande
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

9.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.

Authors:  Y Q Huang; J J Li; M H Kaplan; B Poiesz; E Katabira; W C Zhang; D Feiner; A E Friedman-Kien
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

10.  HSV-2 DNA persistence in astrocytes of the trigeminal root entry zone: double labeling by in situ PCR and immunohistochemistry.

Authors:  P Gressens; J R Martin
Journal:  J Neuropathol Exp Neurol       Date:  1994-03       Impact factor: 3.685

View more
  13 in total

1.  Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  P Rimessi; A Bonaccorsi; M Stürzl; M Fabris; E Brocca-Cofano; A Caputo; G Melucci-Vigo; M Falchi; A Cafaro; E Cassai; B Ensoli; P Monini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.

Authors:  Shou-Jiang Gao; Jian-Hong Deng; Fu-Chun Zhou
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 3.  New and emerging infectious diseases.

Authors:  G L Mandell; G C Townsend
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

Review 4.  Simian homologues of human herpesvirus 8.

Authors:  B Damania; R C Desrosiers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.

Authors:  M Mercader; B Taddeo; J R Panella; B Chandran; B J Nickoloff; K E Foreman
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.

Authors:  F Cerimele; F Curreli; S Ely; A E Friedman-Kien; E Cesarman; O Flore
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Macaque homologs of Kaposi's sarcoma-associated herpesvirus (KSHV) infect germinal center lymphoid cells, epithelial cells in skin and gastrointestinal tract and gonadal germ cells in naturally infected macaques.

Authors:  Helle Bielefeldt-Ohmann; A Gregory Bruce; Kellie Howard; Minako Ikoma; Margaret E Thouless; Timothy M Rose
Journal:  Virology       Date:  2018-04-22       Impact factor: 3.616

8.  Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesis.

Authors:  M M Kennedy; K Cooper; D D Howells; S Picton; S Biddolph; S B Lucas; J O McGee; J J O'Leary
Journal:  Mol Pathol       Date:  1998-02

9.  Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.

Authors:  R Sun; S F Lin; K Staskus; L Gradoville; E Grogan; A Haase; G Miller
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.